COMP-BIO PRODUCTS LIMITED

Company Registration Number:
05998639 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

COMP-BIO PRODUCTS LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

COMP-BIO PRODUCTS LIMITED

Company Information

for the Period Ended 31 March 2025




Director: Angela Francis
Jonathan Francis
Secretary: Jonathan Francis
Registered office: 34
Jos Lane
Shepley
Huddersfield
England
HD8 8DJ
Company Registration Number: 05998639 (England and Wales)

COMP-BIO PRODUCTS LIMITED

Profit and Loss Account

for the Period Ended 31 March 2025


Notes

2025
£

2024
£
Turnover 27,592 41,271
Cost of sales ( 22,555 ) ( 29,852 )
Gross Profit or (Loss) 5,037 11,419
Income from coronavirus (COVID-19) business support grants 0 -
Administrative Expenses ( 14,263 ) ( 18,185 )
Operating Profit or (Loss) ( 9,226 ) ( 6,766 )
Profit or (Loss) Before Tax ( 9,226 ) ( 6,766 )
Profit or (Loss) for Period ( 9,226 ) ( 6,766 )

The notes form part of these financial statements

COMP-BIO PRODUCTS LIMITED

Balance sheet

As at 31 March 2025


Notes

2025
£

2024
£
Fixed assets
Tangible assets: 4 1,256 1,623
Total fixed assets: 1,256 1,623
Current assets
Stocks: 21,225 31,397
Debtors: 5 1,225 2,263
Cash at bank and in hand: 1,211 553
Total current assets: 23,661 34,213
Creditors: amounts falling due within one year: 6 ( 65,253 ) ( 67,113 )
Net current assets (liabilities): ( 41,592 ) ( 32,900 )
Total assets less current liabilities: ( 40,336 ) ( 31,277 )
Creditors: amounts falling due after more than one year: 7 ( 5,899 ) ( 5,899 )
Total net assets (liabilities): ( 46,235 ) ( 37,176 )

The notes form part of these financial statements

COMP-BIO PRODUCTS LIMITED

Balance sheet continued

As at 31 March 2025


Notes

2025
£

2024
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: ( 46,335 ) ( 37,276 )
Shareholders funds: ( 46,235 ) ( 37,176 )

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 December 2025
And Signed On Behalf Of The Board By:

Name: Angela Francis
Status: Director

Name: Jonathan Francis
Status: Director

The notes form part of these financial statements

COMP-BIO PRODUCTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

COMP-BIO PRODUCTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees


    2025

    2024
    Average number of employees during the period 2 2

COMP-BIO PRODUCTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 3. Off balance sheet disclosure

    No

COMP-BIO PRODUCTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Tangible assets

Office equipment Motor vehicles Total
Cost £ £ £
At 01 April 2024 623 1,000 1,623
Additions - - -
Disposals - - -
Revaluations - - -
Transfers - - -
At 31 March 2025 623 1,000 1,623
Depreciation
At 01 April 2024 0 0 0
Charge for year 367 - 367
On disposals - - -
Other adjustments - - -
At 31 March 2025 367 0 367
Net book value
At 31 March 2025 256 1,000 1,256
At 31 March 2024 623 1,000 1,623

COMP-BIO PRODUCTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

5. Debtors


2025
£

2024
£
Trade debtors 1,225 2,263
Total 1,225 2,263

COMP-BIO PRODUCTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

6.Creditors: amounts falling due within one year note


2025
£

2024
£
Bank loans and overdrafts 65,253 67,113
Total 65,253 67,113

COMP-BIO PRODUCTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

7.Creditors: amounts falling due after more than one year


2025
£

2024
£
Bank loans and overdrafts 5,899 5,899
Total 5,899 5,899